Detalhe da pesquisa
1.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood
; 142(24): 2069-2078, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556734
2.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Blood
; 142(2): 172-184, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001051
3.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130297
4.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
5.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer
; 128(9): 1863-1870, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201611
6.
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Blood
; 134(15): 1227-1237, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350265
7.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica
; 106(1): 46-55, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001530
8.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(4): e28929, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559396
9.
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 833-842, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651090
10.
The International Consensus Classification of acute leukemias of ambiguous lineage.
Blood
; 141(18): 2275-2277, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877915
11.
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
Blood
; 131(12): 1350-1359, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284596
12.
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood
; 132(8): 815-824, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997224
13.
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Br J Haematol
; 186(2): 274-285, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957229
14.
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Blood
; 129(25): 3352-3361, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408464
15.
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.
Haematologica
; 104(5): 986-992, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545921
16.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Pediatr Blood Cancer
; 66(6): e27681, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30848065
17.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Blood
; 127(20): 2391-405, 2016 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069254
18.
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).
Br J Haematol
; 177(3): 467-474, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295182
19.
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.
Blood
; 126(8): 964-71, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124497
20.
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
Mod Pathol
; 29(10): 1173-82, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27312067